ELLEN MAYARA SOUZA CRUZ

Ms. ELLEN MAYARA SOUZA CRUZ

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2023 in Antioxidants
Verified
Journal Article
Open access
PDF file
MMMaria Beatriz Madureira
Maria Beatriz Madureira
VCVirginia Marcia Concato
Virginia Marcia Concato
ECELLEN MAYARA SOUZA CRUZ
ELLEN MAYARA SOUZA CRUZ
JMJuliana Maria Bitencourt de Morais
Juliana Maria Bitencourt de Morais
FIFabricio Seidy Ribeiro Inoue
Fabricio Seidy Ribeiro Inoue
‪Wander R. Pavanelli‪Wander R. Pavanelli
‪Wander R. Pavanelli
Citrus (genus Citrus L.) fruits are essential sources of bioactive compounds with antioxidant properties, such as flavonoids. These polyphenolic compounds are divided into subclasses, in which flavanones are the most prominent. Among them, naringenin and hesperidin are emerging compounds with anticancer potential, especially for breast cancer (BC). Several mechanisms have been proposed, including the modulation of epigenetics, estrogen signaling, induction of cell death via regulation of apoptotic signaling pathways, and inhibition of tumor invasion and metastasis. However, this information is sparse in the literature and needs to be brought together to provide an overview of how naringenin and hesperidin can serve as therapeutic tools for drug development and as a successful co-adjuvant strategy against BC. This review detailed such mechanisms in this context and highlighted how naringenin and hesperidin could interfere in BC carcinogenesis and be helpful as potential alternative therapeutic sources for breast cancer treatment.

1 January 2020 in Biology Open
Verified
Journal Article
Open access
PDF file
ECELLEN MAYARA SOUZA CRUZ
ELLEN MAYARA SOUZA CRUZ
JMJuliana Maria Bitencourt de Morais
Juliana Maria Bitencourt de Morais
CRCarlos Vinícius Dalto da Rosa
Carlos Vinícius Dalto da Rosa
MSMellina da Silva Simões
Mellina da Silva Simões
JCJurandir F. Comar
Jurandir F. Comar
FSFabio Seiva
Fabio Seiva
As the number of overweight and obese people has risen in recent years, there has been a parallel increase in the number of people with metabolic syndrome, diabetes and non-alcoholic fatty liver disease. The consumption of artificially sweetened beverages contributes to these epidemics. This study investigated the long-term effects of ingestion of a 40% sucrose solution on serum and hepatic parameters in male Wistar rats (Rattus norvegicus). After 180 days, the glycemic response, lipid profile and hepatic oxidative stress were compared to those of rats maintained on water. Sucrose ingestion led to higher body weight, increased fat deposits, reduced voluntary food intake and reduced feeding efficiency. Rats that received sucrose solution showed early signs of glucose intolerance and insulin resistance, such as hyperinsulinemia. Serum triacylglycerol (TG), very-low density lipoprotein (VLDL), cholesterol, ALT and AST levels increased after sucrose consumption. Elevated malondialdehyde and superoxide dismutase (SOD) levels and reduced glutathione levels characterize the hepatic oxidative stress due to sucrose ingestion. Liver sample histology showed vacuolar traces and increased fibrotic tissue. Our data showed the harmful effects of chronic consumption of sucrose solution, which can cause alterations that are found frequently in obesity, glucose intolerance and non-alcoholic hepatic disease, characteristics of metabolic syndrome.

Verified
Journal Article
Open access
PDF file
MSMilena Cremer de Souza
Milena Cremer de Souza
MAMaria Agneis
Maria Agneis
KNKaroliny Alves das Neves
Karoliny Alves das Neves
MAMatheus Ribas de Almeida
Matheus Ribas de Almeida
GFGeórgia Feltran
Geórgia Feltran
FSFabio Seiva
Fabio Seiva
Type 2 diabetes mellitus represents a major global health burden and is often preceded by a prediabetic state characterized by insulin resistance and metabolic dysfunction. Mitochondrial alterations, oxidative stress, and disturbances in lipid metabolism are central to the prediabetes pathophysiology. Melatonin, a pleiotropic indolamine, is known to regulate metabolic and mitochondrial processes; however, its therapeutic potential in prediabetes remains poorly understood. This study investigated the effects of melatonin on energy metabolism, oxidative stress, and mitochondrial function in a rat model of prediabetes induced by chronic sucrose intake and low-dose streptozotocin administration. Following prediabetes induction, animals were treated with melatonin (20 mg/kg) for four weeks. Biochemical analyses were conducted to evaluate glucose and lipid metabolism, and mitochondrial function was assessed via gene expression, enzymatic activity, and oxidative stress markers. Additionally, hepatic mitochondrial dynamics were examined by quantifying key regulators genes associated with biogenesis, fusion, and fission. Prediabetic animals exhibited dyslipidemia, hepatic lipid accumulation, increased fat depots, and impaired glucose metabolism. Melatonin significantly reduced serum glucose, triglycerides, and total cholesterol levels, while enhancing the hepatic high-density lipoprotein content. It also stimulated β-oxidation by upregulating hydroxyacyl-CoA dehydrogenase and citrate synthase activity. Mitochondrial dysfunction in prediabetic animals was evidenced by the reduced expression of peroxisome proliferator-activated receptor gamma coactivator-1 alpha and mitochondrial transcription factor A, both of which were markedly upregulated by melatonin. The indolamine also modulated mithocondrial dynamics by regulating fusion and fission markers, including mitosuin 1 and 2, optic atrophy protein, and dynamin-related protein. Additionally, melatonin mitigated oxidative stress by enhancing the activity of superoxide dismutase and catalase while reducing lipid peroxidation. These findings highlight melatonin’s protective role in prediabetes by improving lipid and energy metabolism, alleviating oxidative stress, and restoring mitochondrial homeostasis. This study provides novel insights into the therapeutic potential of melatonin in addressing metabolic disorders, particularly in mitigating mitochondrial dysfunction associated with prediabetes.

15 March 2022 in Phytomedicine Plus
Verified
Journal Article
Open access
Luiz Gustavo ChuffaLuiz Gustavo Chuffa
Luiz Gustavo Chuffa
MSMilena Cremer de Souza
Milena Cremer de Souza
ECELLEN MAYARA SOUZA CRUZ
ELLEN MAYARA SOUZA CRUZ
FFFrancielle Belinelli Ferreira
Francielle Belinelli Ferreira
JMJuliana Maria Bitencourt de Morais
Juliana Maria Bitencourt de Morais
FSFabio Seiva
Fabio Seiva

14 July 2026 in Archives of Toxicology
Verified
Journal Article
Open access
ECELLEN MAYARA SOUZA CRUZ
ELLEN MAYARA SOUZA CRUZ
VCVirginia Márcia Concato-Lopes
Virginia Márcia Concato-Lopes
MDMariana Barbosa Detoni
Mariana Barbosa Detoni
MGManoela Daiele Gonçalves-Lens
Manoela Daiele Gonçalves-Lens
MSMilena Cremer de Souza
Milena Cremer de Souza
‪Wander R. Pavanelli‪Wander R. Pavanelli
‪Wander R. Pavanelli
Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related mortality worldwide, and the search for novel therapeutic strategies is ongoing. Chalcones, a class of naturally occurring and synthetically derived open-chain flavonoid precursors, have attracted attention because of their chemical versatility and broad biological activity. This review synthesizes current findings on the molecular mechanisms through which chalcones exert their effects in NSCLC, including modulation of oxidative stress, epithelial-mesenchymal transition, DNA damage responses, and diverse cell death pathways. Chalcones have been shown to interfere with key signaling cascades, such as TGF-β, PI3K/AKT/mTOR, JAK/STAT, and Wnt/β-catenin, with reported effects on tumor proliferation, migration, invasion, and therapy resistance. Their structural flexibility enables chemical optimization aimed at improve potency, selectivity, and pharmacokinetic profiles, supporting further preclinical investigation. Despite promising preclinical results, challenges remain regarding pharmacokinetics, bioavailability, and context-dependent off-target effects. Future research should prioritize integrated mechanistic studies, structure-activity relationship analyses, selective cytotoxicity assessment, and advanced delivery strategies to improve tumor specificity. Chalcones represent chemically versatile multitarget scaffolds for further optimization in NSCLC, particularly in strategies aimed at exploiting epithelial-mesenchymal plasticity, redox adaptation, and regulated cell death.

20 June 2026 in Pathogens
Verified
Journal Article
Open access
PDF file
ACAmanda Cristina Machado Cristina Machado Carloto
Amanda Cristina Machado Cristina Machado Carloto
ARAna Carolina Jacob Rodrigues
Ana Carolina Jacob Rodrigues
MDMariana Barbosa Detoni
Mariana Barbosa Detoni
ECELLEN MAYARA SOUZA CRUZ
ELLEN MAYARA SOUZA CRUZ
VCVirgínia Márcia Concato-Lopes
Virgínia Márcia Concato-Lopes
‪Wander R. Pavanelli‪Wander R. Pavanelli
‪Wander R. Pavanelli
Leishmaniasis is a neglected tropical disease caused by parasites of the genus Leishmania. Curcumin (CUR) is a polyphenol with several biological properties, including antimicrobial effects. However, its low bioavailability remains a challenge, and nanoencapsulation may represent a useful strategy to overcome this limitation. This study aimed to evaluate, in vitro, the antipromastigote activity of free CUR and the antiamastigote effect of CUR nanoparticles and their association with antimoniate, as well as to elucidate possible mechanisms of action. Free CUR directly inhibited promastigote proliferation, with an IC50 of 25 µM at 24 h. CUR induced mitochondrial hyperpolarization, increased the production of reactive oxygen species (ROS) and nitric oxide (NO), and enhanced lipid peroxidation and the accumulation of lipid droplets in promastigotes. These alterations were associated with autophagic and apoptotic processes, morphological and ultrastructural changes, DNA fragmentation, and cell cycle arrest. Free CUR also reduced the viability of BALB/c peritoneal macrophages, and this effect was attenuated after nanoencapsulation. Free CUR, CUR nanoparticles, and their association with antimoniate (AM) reduced both the percentage of infected macrophages and the number of intracellular amastigotes at all tested concentrations, with increased NO production observed at the highest concentrations of free CUR. Altogether, our findings suggest that CUR exerts leishmanicidal activity against promastigotes by disrupting oxidative metabolism and triggering autophagic and apoptotic pathways, while amastigote elimination appears to occur through mechanisms independent of oxidative stress.